Skip to content

MERCK LIFE SCIENCE

Active
Private limited companyfounded 198442 yrs activeIldefonse Vandammestraat 5/7B, 1560 Hoeilaart, BelgiumKBO/BCE: BE 0425.578.392

MERCK LIFE SCIENCE has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €34.04M and a net result of €8.56M. Equity is shrinking by ~14.1% per year across the filed fiscal years. Its solvency ranks better than 92% of 5988 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2024
94 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability92▲+14
Solvency100▲+28
Growth72=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity ample (current ratio 8.62 against 2.44 in 2023; short-term debt: 11.6% of total assets), and 13.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 42 years 0 50 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
86.3%
Return on assets
21.7%
Age of the figures
21 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year €34.04M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
34 d early
2023
36 d early
2022
42 d early
2021
5 d early
2020
3 d early
2019
28 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover
€161.19M▼ 5.9%
2023 · €171.33M
2018: €26.02M 2019: €28.39M 2020: €29.65M 2021: €165.88M 2022: €172.72M 2023: €171.33M
2018 → 2024
EBIT margin
6.8%▼ 0.4pp
2023 · 7.2%
2018: 4.6% 2019: 2.7% 2020: 4.4% 2021: 8.0% 2022: 6.1% 2023: 7.2%
2018 → 2024
Net result
€8.56M▼ 15.1%
2023 · €10.07M
2018: €1.32M 2019: €988k 2020: €1.56M 2021: €10.07M 2022: €7.90M 2023: €10.07M
2018 → 2024
Working capital
€34.88M▲ 10.1%
2023 · €31.66M
2018: €6.13M 2019: €5.77M 2020: €52.40M 2021: €41.85M 2022: €31.99M 2023: €31.66M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Turnover€29.65M-€165.88M▲ 459%€172.72M▲ 4.1%€171.33M▼ 0.8%€161.19M▼ 5.9%
Equity€51.65M-€35.51M▼ 31.3%€30.41M▼ 14.4%€25.49M▼ 16.2%€34.04M▲ 33.6%
Operating result€1.29M-€13.30M▲ 931%€10.60M▼ 20.3%€12.36M▲ 16.6%€10.93M▼ 11.6%
Net result€1.56M-€10.07M▲ 547%€7.90M▼ 21.5%€10.07M▲ 27.5%€8.56M▼ 15.1%
Result per fiscal year
Operating resultNet result
€0€5.00M€10.00M€15.00MOperating result 2020: €1.29M€1.29MNet result 2020: €1.56M€1.56MOperating result 2021: €13.30M€13.30MNet result 2021: €10.07M€10.07MOperating result 2022: €10.60M€10.60MNet result 2022: €7.90M€7.90MOperating result 2023: €12.36M€12.36MNet result 2023: €10.07M€10.07MOperating result 2024: €10.93M€10.93MNet result 2024: €8.56M€8.56M20202021202220232024
The operating result falls in 2024; 2024 is 12% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €39.45M
Fixed assets €200=
Current assets €39.45M▼ 26.5%
Equity and liabilities €39.45M
Equity €34.04M▲ 33.6%
Provisions €2k▼ 100.0%
Debt €5.41M▼ 77.0%
The debt ratio falls from 43.7% to 13.7%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
Solvency
86.3%
2023 · 47.5%
Current ratio
8.62
2023 · 2.44
Quick ratio
8.53
2023 · 2.43
Debt / equity
0.16
2023 · 0.92
ROE
25.1%
2023 · 39.5%
ROA
21.7%
2023 · 18.8%
Debt
€5.41M
2023 · €23.49M
Debt ≤ 1 year
€4.58M
2023 · €22.03M
Income taxes
€3.01M
2023 · €2.96M
Staff costs
€7.31M
2023 · €7.10M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€53.69M€39.45M
Fixed assets21/28€200€200=
Financial fixed assets28€200€200=
Other financial fixed assets284/8€200€200=
Amounts receivable and cash guarantees285/8€200€200=
Current assets29/58€53.69M€39.45M
Stocks and contracts in progress3€259k€437k
Stocks30/36€178k€262k
Goods purchased for resale34€178k€262k
Contracts in progress37€81k€175k
Amounts receivable within one year40/41€25.91M€39.02M
Trade receivables40€25.77M€29.78M
Other amounts receivable41€142k€9.23M
Cash at bank and in hand54/58€27.52M-
Equity and liabilities
Total equity and liabilities10/49€53.69M€39.45M
Equity10/15€25.49M€34.04M
Contributions10/11€25.48M€25.48M=
Reserves13€11k€11k=
Non-distributable reserves130/1€11k€11k=
Reserves not available under the articles1311€11k€11k=
Profit (loss) carried forward14-€8.56M
Provisions and deferred taxes16€4.72M€2k
Provisions for liabilities and charges160/5€4.72M€2k
Other liabilities and charges164/5€4.72M€2k
Amounts payable17/49€23.49M€5.41M
Amounts payable within one year42/48€22.03M€4.58M
Financial debts43-€59
Credit institutions430/8-€59
Trade debts44€935k€674k
Suppliers440/4€935k€674k
Taxes, remuneration and social security45€6.09M€3.90M
Taxes450/3€4.34M€2.34M
Remuneration and social security454/9€1.75M€1.57M
Other amounts payable47/48€15.00M-
Accrued charges and deferred income492/3€1.46M€833k
Income statement Code20232024
Operating income70/76A€171.39M€161.35M
Turnover70€171.33M€161.19M
Change in stocks of work in progress, finished goods and contracts in progress71€49k€94k
Other operating income74€13k€64k
Operating charges60/66A€159.03M€150.42M
Goods for resale, raw materials and consumables60€143.52M€139.16M
Purchases600/8€143.58M€139.25M
Change in stocks: decrease (increase)609€-62k€-84k
Services and other goods61€3.28M€3.72M
Remuneration, social security and pensions62€7.10M€7.31M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€461k-
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€107k
Provisions for liabilities and charges: additions (uses and reversals)635/8€4.62M-
Other operating charges640/8€50k€118k
Operating profit (loss)9901€12.36M€10.93M
Financial income75/76B€682k€677k
Recurring financial income75€682k€677k
Income from current assets751€682k€643k
Other financial income752/9-€34k
Financial charges65/66B€9k€38k
Recurring financial charges65€9k€38k
Debt charges650-€19k
Other financial charges652/9€9k€19k
Profit (loss) for the period before taxes9903€13.03M€11.57M
Income taxes67/77€2.96M€3.01M
Taxes670/3€2.96M€3.01M
Profit (loss) for the period9904€10.07M€8.56M
Profit (loss) for the period to be appropriated9905€10.07M€8.56M
Appropriation of the result
Profit (loss) to be appropriated9906€10.07M€8.56M
Transfer from equity791/2€4.93M-
From contributions791€4.93M-
Profit to be distributed694/7€15.00M-
Return on contributions (dividend)694€15.00M-
Social balance
Average headcount (FTE)908745.647.1

The notes to these accounts (41 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
27-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Liquidity quadruplescurrent ratio 8.62
Current ratio from 2.44 to 8.62; short-term debt falls from €22.03M to €4.58M.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Highest result since 2018net €10.07M ▲27.5%
Net result €10.07M, the highest in the series.
19-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
26-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
28-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
18-05
State Gazette act Board meeting · Corporate purpose
Purpose change · Name change
2020
31-12
Financial Liquidity quadruplescurrent ratio 47.85
Current ratio from 13.09 to 47.85.
03-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Weakest financial yearnet €988k ▼25%
Net result drops to €988k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity doublescurrent ratio 13.09
Current ratio from 5.69 to 13.09; short-term debt falls from €1.30M to €478k.
02-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
09-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
09-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 9 days late
2016
27-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 27 acts read
About the unread acts

We know of 27 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
27 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoeilaart · 1 establishment unit since 1992
seat establishment approximate The establishment unit on the map
Ground area
3,343 m²
Building footprint
1,079 m²
Volume, LiDAR
12,741 m³
Parcel 23033C0080/00H016, Flanders · tallest building 17.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Merck Life Science
Ildefonse Vandammestraat 5/7, 1560 HoeilaartNACE 5151003
since 19922.024.525.305
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23033C0080/00H016 Flanders 3,343 m² 1 · 1,079 m² 17.1 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Acquisitions and mergers

1 transaction
Received a contribution from:Merck Chemicals N.V/S.A.
BE 0408.308.434proposal · State Gazette act of 18-05-2021 · effective 01-07-2021

Group per the LEI register

1 parent company
Parent company:E. Merck KG
Darmstadt, Germany

Public money · subsidies and aid

European Union, budget

2022 · 1 entry · 45,000 EUR in total
Year Entries awarded
2022 1 45,000 EUR
Projects
MAINTENANCE WATER PURIFICATION SYSTEMS
1.0.11 - Horizon Europe · 16-03-2022 to 15-03-2026 · 45,000 EUR

Recognitions · licences · registrations

Food safety, FASFC

1 site
Hoeilaart2.024.525.305
1 permission
Trader · since 02-03-2022

Legal Entity Identifier

9676002UEU8TBM0Q9V67
live in the LEI register

Similar companies · same sector, comparable size

Of 1,229 companies in sector 46851 we hold annual accounts for 516. 134 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded16-03-1984
Fiscal year end31-12
Activities, NACEBEL
46851Wholesale of industrial chemicals
51550
46460Wholesale of pharmaceutical and medical goods
46869Wholesale trade
Sources
Crossroads Bank for EnterprisesNational Bank · 43 filingsAddress and cadastre registers

Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.